ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

IVAN VELAZQUEZ M.D

3051 AVE JUAN HERNANDEZ ORTIZ EDIFICIO TAVAREZ MEDICAL #4

Isabela | Puerto Rico | 00662

(787) 872-5860

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,158Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 36

$361K Total Retail Price of All Prescriptions

Rank: 7 out of 36

571 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 571 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 6,546 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $32 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
RANITIDINE HCL 339 259 1 5
ENALAPRIL MALEATE 328 259 2 3
OMEPRAZOLE 310 220 3 6
GABAPENTIN 300 230 4 4
METFORMIN HCL 264 185 5 2
SIMVASTATIN 224 159 6 1
AZITHROMYCIN 194 128 7 26
AMLODIPINE BESYLATE 166 147 8 7
FUROSEMIDE 155 125 9 11
LOSARTAN POTASSIUM 152 126 10 8
PLAVIX 148 131 11 47
LOSARTAN-HYDROCHLOROTHIAZIDE 148 115 11 15
GLYBURIDE-METFORMIN HCL 146 116 R 13 34
SYNTHROID 145 92 14 14
TRAMADOL HCL 119 56 15 23
NAMENDA 117 116 16 71
TRAMADOL HCL-ACETAMINOPHEN 115 90 17 20
CLOPIDOGREL 112 92 18 52
CIPROFLOXACIN HCL 112 76 18 27
LEVOFLOXACIN 103 75 20 89
ATENOLOL 91 60 21 9
DONEPEZIL HCL 86 77 22 58
LEVOTHYROXINE SODIUM 85 69 23 12
GLIPIZIDE 83 62 24 10
FAMOTIDINE 83 49 24 39
PREDNISOLONE 80 50 26 107
DIOVAN 79 75 27 48
QUETIAPINE FUMARATE 77 49 28 123
AMLODIPINE BESYLATE-BENAZEPRIL 76 48 29 36
METOPROLOL TARTRATE 75 47 30 18
PHENYTOIN SODIUM EXTENDED 75 60 30 160
DIPYRIDAMOLE 73 71 R 32 77
SERTRALINE HCL 71 65 33 50
SINGULAIR 70 34 34 129
INSULIN SYRINGE 68 62 35 55
DIOVAN HCT 66 44 36 61
LANTUS 65 53 37 49
NABUMETONE 62 25 38 17
DICLOFENAC POTASSIUM 62 46 38 32
CARVEDILOL 59 57 40 37
ISOSORBIDE DINITRATE 57 57 41 67
LEVETIRACETAM 56 31 42 182
CAPTOPRIL 55 55 43 29
HUMULIN 70-30 54 41 44 45
CITALOPRAM HBR 53 31 45 90
GLIMEPIRIDE 52 37 46 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.